Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Chiara Sghirlanzoni
Maria Chiara Sghirlanzoni
Medicine
Rituximab
Nephrotic syndrome
Endocrinology
Internal medicine
5
Papers
250
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An enigmatic case of IgG4-related nephropathy and an updated review of the literature.
2021
Clinical and Experimental Medicine
Leonardo Spatola
Federica Ravera
Maria Chiara Sghirlanzoni
Simona Verdesca
Alberto Menegotto
Marialuisa Querques
Mario Livio Pietro Camozzi
Valeriana Giuseppina Colombo
E. Minetti
Show All
Source
Cite
Save
Citations (2)
Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study
2011
American Journal of Nephrology
Paolo Cravedi
Maria Chiara Sghirlanzoni
Maddalena Marasà
Alessandra Salerno
Giuseppe Remuzzi
Piero Ruggenenti
Show All
Source
Cite
Save
Citations (54)
Thrice-weekly in-center nocturnal hemodialysis: An effective strategy to optimize chronic dialysis therapy
2009
International Journal of Artificial Organs
Paolo Cravedi
Piero Ruggenenti
Giulio Mingardi
Maria Chiara Sghirlanzoni
Giuseppe Remuzzi
Show All
Source
Cite
Save
Citations (18)
Effects of Rituximab on Morphofunctional Abnormalities of Membranous Glomerulopathy
2008
Clinical Journal of The American Society of Nephrology
Piero Ruggenenti
Paolo Cravedi
Maria Chiara Sghirlanzoni
Elena Gagliardini
Sara Conti
Flavio Gaspari
Gianfranco Marchetti
Mauro Abbate
Giuseppe Remuzzi
Show All
Source
Cite
Save
Citations (53)
Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
2007
Clinical Journal of The American Society of Nephrology
Paolo Cravedi
Piero Ruggenenti
Maria Chiara Sghirlanzoni
Giuseppe Remuzzi
Show All
Source
Cite
Save
Citations (123)
1